Keratoconjunctivitis clinical trials
The registry lists 117 studies for Keratoconjunctivitis across more than 10 countries. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 87
- Status unknown
- 15
- Active, not recruiting
- 4
- Withdrawn
- 4
- Terminated
- 3
- Not yet recruiting
- 3
Phase
- Phase 2
- 28
- Phase 3
- 25
- Phase 4
- 16
- Phase 1
- 9
- Early Phase 1
- 1
Where
- United States
- 50
- France
- 11
- Italy
- 9
- Taiwan
- 7
- United Kingdom
- 4
- Denmark
- 4
Who runs them
National Taiwan University Hospital (5) · C.O.C. Farmaceutici S.r.l. (5) · Oculeve, Inc. (4) · Kala Pharmaceuticals, Inc. (4) · Allergan (4) · Santen SAS (3) · Mimetogen Pharmaceuticals USA, Inc. (3) · Sun Pharmaceutical Industries Limited (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 117 — search for more.
- Autologous Serum Obtained by a Closed-Circuit Collection DeviceNot yet recruitingNCT07014059Phase 21 country
- Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal KeratoconjunctivitisNot yet recruitingNCT06793514Phase 1
- Corneal Topography in Vernal KeratoconjunctivitisNot yet recruitingNCT067464671 country
- Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)RecruitingNCT04296864Phase 21 country
- Tolerability Comparison of Flarex to Lotemax SMCompletedNCT07588074Phase 41 country
- 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or KeratoconjunctivitisActive, not recruitingNCT04685109Not applicable1 country
- A Study Evaluating the Safety of the Nasal PumpTerminatedNCT06329687Phase 41 country
- Topical rVA576 for Treatment of Atopic KeratoconjunctivitisTerminatedNCT04037891Phase 1/22 countries
- Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical SteroidsActive, not recruitingNCT069137901 country
- Ocular Comorbidity in Atopic DermatitisActive, not recruitingNCT049733841 country
- Goblet Cell Response and Dry Eye Symptoms After PRK and LASIKCompletedNCT00411827Not applicable1 country
- The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU PatientsCompletedNCT06539663Phase 2/31 country
- Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT05848128Phase 31 country
- A Randomized Study of Smile Exercise for Dry EyeCompletedNCT04421300Not applicable1 country
- PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye SymptomsCompletedNCT05807360Not applicable1 country
- PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal AbnormalitiesCompletedNCT05823961Not applicable1 country
- A Phase I Study of PP-001 Eye Drops in Healthy Adult VolunteersCompletedNCT03769454Phase 11 country
- Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye DiseaseCompletedNCT03878628Early Phase 11 country
- Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE FittingCompletedNCT04649177Not applicable1 country
- Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort BActive, not recruitingNCT05618730Phase 11 country
- Phase 4 Study Evaluating the Safety of the Nasal Guide With TyrvayaCompletedNCT05918406Phase 41 country
- AONDA Therapeutic Indication Study ICompletedNCT058911061 country
- Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseaseCompletedNCT05119920Phase 21 country
- PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye SymptomsCompletedNCT05825352Not applicable1 country
- PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye SymptomsCompletedNCT05825599Not applicable1 country
- PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye SymptomsCompletedNCT05825586Not applicable1 country
- Tavilermide Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT03925727Phase 31 country
- Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's SyndromeCompletedNCT04615455Phase 21 country
- Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry EyeCompletedNCT044936581 country
- Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)CompletedNCT03418259Not applicable1 country
- Amniotic Membrane Treatment for Hyposecretory Dry EyeCompletedNCT05598242Phase 31 country
- Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02688556Phase 31 country
- Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02254265Phase 2/31 country
- Trial of CF101 to Treat Patients With Dry Eye DiseaseCompletedNCT01235234Phase 31 country
- Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis SiccaCompletedNCT00349466Phase 21 country
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis TrialCompletedNCT05353101Phase 11 country
- HORMONES IN VERNAL KERATOCONJUNCTIVITISCompletedNCT050382411 country
- Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
- Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal KeratoconjunctivitisCompletedNCT01751126Phase 311 countries
- Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)CompletedNCT00328653Phase 2/31 country
- Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye SyndromeCompletedNCT04147650Phase 2/31 country
- An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02845674Phase 3
- Evaluation of the Efficacy and Safety of Tacrolimus Drops in Children With Vernal KeratoconjunctivitisCompletedNCT050760841 country
- Tear Production by Nasal Neurostimulation Compared to Active ControlCompletedNCT02970799Not applicable
- Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)CompletedNCT01421498Phase 31 country
- Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy StudyStatus unknownNCT04884217Phase 21 country
- Safety and Efficacy of KPI-121 in Subjects With DEDCompletedNCT03616899Phase 31 country
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02813265Phase 31 country
- Topical Immuonosuppressant Drugs in Spring CatarrhStatus unknownNCT04705584Not applicable1 country
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02188160Phase 21 country